BSEOthers4h ago · 22 Jul 2026, 01:37 pm
Compliance -57 (5)
Transgene Biotek Ltd · 526139
✦ AI Summary
Transgene Biotek Ltd has informed that Regulation 57(5) of SEBI (LODR) Regulations, 2015 is not applicable to the company for the quarter ended June 30, 2026, as no non-convertible securities were issued.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Transgene Biotek Ltd - 526139 - Compliance-57 (5) : intimation after the end of quarter
Attachments (1)
📄pdf
Download →
c7e0ffb2-e3a0-4ceb-9e59-87a0f57c8d14.pdf
View document text
Date 22-07-2026
The General Manager
Department of Corporate Services – CRD
BSE LIMITED Phiroze Jeejeebhoy Towers
Dalal Street,Mumbai 400 001.
Subject: Non-Applicability of Reg. 57(5) of SEBI (LODR) Regulations,
2015.
As per the Captioned Subject, we hereby inform you that Company has not issued
any Non-Convertible Securities. So, the Regulation 57(5) of SEBI (LODR) Regulation,
2015 is Not Applicable to the Company for the Quarter ended as on 30th June, 2026
Compliance Remarks
A certificate confirming the payment of Not Applicable
interest/dividend/principal obligations for
nonconvertible securities which were due
in that quarter;
The details of all unpaid Not Applicable
interest/dividend/principal obligations in
relation to non-convertible securities at
the end of the quarter
We kindly request you to take the above said on record.
Thanking You,
Yours faithfully
For TRANSGENE BIOTEK LIMITED
DR K KOTESWARA RAO
CHAIRMAN & MANAGING DIRECTOR
Plot 69 & 70IDA Bollaram, Sangareddy District–502 325, Telangana, India
Ph: +91-40-65589499 Fax: +91-8458-279755 Web:www.transgenebiotek.com
Email:info@transgenebiotek.com, CIN No: L85195AP1990PLC011065